Table 2.
IL-1B genotype and allele frequency for patients with GDM.
| IL-1B loci | Control group ( N = 280) | GDM group ( N = 160) | OR (95% CI) a | p a | ||
|---|---|---|---|---|---|---|
| n | Percentage (%) | n | Percentage (%) | |||
| −511 C/T | ||||||
| CC | 69 | 24.6 | 20 | 10.0 | 1.00REF | |
| TC | 71 | 25.4 | 44 | 27.5 | 2.12 (1.37–3.30) | < 0.001 |
| TT | 140 | 50.0 | 96 | 62.5 | 2.34 (1.57–3.48) | < 0.001 |
| C | 209 | 37.3 | 84 | 23.6 | 1.00REF | |
| T | 351 | 62.7 | 236 | 76.4 | 1.66 (1.34–2.06) | < 0.001 |
| +3954 C/T | ||||||
| CC | 146 | 52.1 | 82 | 51.2 | 1.00REF | |
| TC | 112 | 40.0 | 64 | 40.0 | 1.02 (0.76–1.36) | 0.907 |
| TT | 22 | 7.9 | 14 | 8.8 | 1.13 (0.68–1.89) | 0.632 |
| C | 404 | 72.1 | 228 | 71.3 | 1.00REF | |
| T | 156 | 27.9 | 92 | 28.7 | 1.04 (0.84–1.30) | 0.689 |
Note: The bolded data are significant in terms of statistics. “REF” represents “reference group.”
Abbreviations: CI, confidence interval; GDM, gestational diabetes mellitus; OR, odds ratio.
aAdjusted for sex and age by logistic regression model.